FBI, Pentagon helped research facial recognition for street cameras, drones
By Drew Harwell,
The Washington Post
| 03. 07. 2023
The FBI and the Defense Department were actively involved in research and development of facial recognition software that they hoped could be used to identify people from video footage captured by street cameras and flying drones, according to thousands of pages of internal documents that provide new details about the government’s ambitions to build out a powerful tool for advanced surveillance.
The documents, revealed in response to an ongoing Freedom of Information Act lawsuit the American Civil Liberties Union filed against the FBI, show how closely FBI and Defense officials worked with academic researchers to refine artificial-intelligence techniques that could help in the identification or tracking of Americans without their awareness or consent.
Many of the records relate to the Janus program, a project funded by the Intelligence Advanced Research Projects Agency, or IARPA, the high-level research arm of the U.S. intelligence community modeled after the Pentagon’s Defense Advanced Research Projects Agency, known as DARPA.
Program leaders worked with FBI scientists and some of the nation’s leading computer-vision experts to design and test software that would quickly and accurately process...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...